Case Report
Published on 22 Sep 2023
Case report: Primary cardiac lymphoma manifesting as superior vena cava syndrome
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1257734
- 2,539 views
- 2 citations
Type at least 3 characters
295 articles
Review
Published on 15 Sep 2023
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1223660
- 5,599 views
- 10 citations
Opinion
Published on 15 Sep 2023
The broad spectrum of cardiotoxicities from immunotherapies
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1259620
- 2,036 views
- 2 citations
Systematic Review
Published on 14 Sep 2023
Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1212174
- 6,685 views
- 5 citations
Review
Published on 08 Sep 2023
Cardiotoxicity of anti-cancer drugs: cellular mechanisms and clinical implications
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1150569
- 4,570 views
- 7 citations
Brief Research Report
Published on 01 Sep 2023
Clinical presentation and neurovascular manifestations of cardiac myxomas and papillary fibroelastomas: a retrospective single-institution cohort study
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1222179
- 1,545 views
- 1 citation
Review
Published on 30 Aug 2023
Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1243531
- 5,932 views
- 5 citations
Case Report
Published on 22 Aug 2023
Case report: Sodium-glucose cotransporter 2 inhibitors induce left ventricular reverse remodeling in anthracycline-related cardiac dysfunction—a case series
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1250185
- 1,961 views
- 9 citations
Original Research
Published on 04 Aug 2023
Cardiovascular mortality by cancer risk stratification in patients with localized prostate cancer: a SEER-based study
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1130691
- 4,153 views
- 13 citations
Systematic Review
Published on 03 Aug 2023
Chemotherapy induced right ventricular cardiomyopathy; a systematic review and meta-analysis
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1103941
- 3,620 views
- 11 citations
Original Research
Published on 02 Aug 2023
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1179968
- 2,552 views
Editorial
Published on 13 Jul 2023
Editorial: Case reports in cardio-oncology: 2022
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1235015
- 2,510 views
- 2 citations
Review
Published on 10 Jul 2023
The characteristics of invasive cardiac lipoma: case report and literature review
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1195582
- 3,504 views
- 6 citations
Review
Published on 05 Jul 2023
Cardiovascular toxicity from therapies for light chain amyloidosis
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1212983
- 5,608 views
- 3 citations
Editorial
Published on 20 Jun 2023
Editorial: Cardiovascular sequelae of chemotherapy and radiotherapy in cancer survivors: current evidence and perspectives
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1230862
- 1,548 views
Original Research
Published on 20 Jun 2023
Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1181806
- 4,318 views
- 5 citations